Inspire Investing LLC decreased its position in HealthStream, Inc. (NASDAQ:HSTM – Free Report) by 11.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,040 shares of the technology company’s stock after selling 5,032 shares during the quarter. Inspire Investing LLC owned 0.13% of HealthStream worth $1,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also bought and sold shares of the company. GAMMA Investing LLC raised its stake in shares of HealthStream by 36.0% during the third quarter. GAMMA Investing LLC now owns 1,355 shares of the technology company’s stock worth $39,000 after acquiring an additional 359 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in HealthStream by 10.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,671 shares of the technology company’s stock worth $270,000 after purchasing an additional 876 shares during the period. Quarry LP bought a new stake in HealthStream in the third quarter worth $27,000. Ellsworth Advisors LLC boosted its position in HealthStream by 5.1% during the third quarter. Ellsworth Advisors LLC now owns 20,035 shares of the technology company’s stock valued at $578,000 after buying an additional 972 shares during the period. Finally, Point72 DIFC Ltd bought a new position in shares of HealthStream during the second quarter valued at about $38,000. Hedge funds and other institutional investors own 69.58% of the company’s stock.
HealthStream Price Performance
NASDAQ HSTM opened at $32.16 on Friday. The business’s 50-day moving average is $32.06 and its 200 day moving average is $30.08. The stock has a market capitalization of $978.15 million, a PE ratio of 49.48, a PEG ratio of 4.15 and a beta of 0.40. HealthStream, Inc. has a 1 year low of $23.92 and a 1 year high of $33.52.
Wall Street Analyst Weigh In
HSTM has been the subject of a number of recent research reports. Barclays boosted their target price on HealthStream from $32.00 to $34.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Canaccord Genuity Group boosted their price objective on HealthStream from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Finally, Craig Hallum upgraded shares of HealthStream to a “strong-buy” rating in a report on Thursday, October 17th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, HealthStream presently has an average rating of “Buy” and an average price target of $31.50.
Read Our Latest Analysis on HSTM
About HealthStream
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Recommended Stories
- Five stocks we like better than HealthStream
- What is a SEC Filing?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Where Do I Find 52-Week Highs and Lows?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How is Compound Interest Calculated?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding HSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthStream, Inc. (NASDAQ:HSTM – Free Report).
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.